Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement

Applied DNA Sciences, Inc. (NASDAQ:APDN), a leader in PCR-based DNA technologies, has announced that it received a notification from Nasdaq confirming the company has regained compliance with the minimum bid price requirement.

Previously, on July 12, 2024, Applied DNA was informed that its stock failed to maintain the minimum bid price of $1.00 over a span of 30 consecutive business days. To regain compliance, the stock's closing bid price needed to reach at least $1.00 for 10 consecutive business days, extendable up to 20 days.

On September 17, 2024, Nasdaq verified that the company's stock closed at or above $1.00 per share for 20 consecutive business days from August 19 to September 16, 2024. This rectified the compliance issue, and Nasdaq has since closed the matter.